Historical record - last NADAC effective date: 1/22/2020
Product Information
GABAPENTIN 300 MG CAPSULE is a generic product labeled by Amneal Pharmaceuticals of New York LLC, priced at $0.0517 per EA under NDC 53746010210. Its NADAC has been published 324 times since Nov 28, 2013.
FDA first approved this application on Jul 25, 2007. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
300 mg/1
Manufacturer
Amneal Pharmaceuticals of New York LLCNDC
53746010210
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
1/22/2020
Active Ingredients
GABAPENTINApproval Type
Generic (ANDA)
FDA Application
ANDA078428FDA Approved
7/25/2007
TE Code
AB
On Market Since
11/24/2009
Pharmacological Classes
Price Statistics
The NADAC for GABAPENTIN 300 MG CAPSULE has been published 324 times since Nov 28, 2013, and over the history we have for it it has declined 8.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0517 per EA |
|---|---|
| All-time high | $0.0676 (Feb 12, 2014) |
| All-time low | $0.0396 (Apr 19, 2017) |
| Median price | $0.0470 |
| Average price | $0.0484 |
| Largest weekly change | +18.3% (Jan 22, 2014) |
| Weeks tracked | 324 |
| Tracking since | Nov 28, 2013 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
N/A
All
-8.3%
Last surveyed Feb 5, 2020 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 17 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 42% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of GABAPENTIN 300 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for GABAPENTIN 300 MG CAPSULE, manufactured by Amneal Pharmaceuticals of New York LLC, is $0.0517 per EA (NDC 53746010210), effective Feb 5, 2020.
How has the price of GABAPENTIN 300 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for GABAPENTIN 300 MG CAPSULE has declined 8.3%. It has been tracked across 324 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for GABAPENTIN 300 MG CAPSULE?
Since Nov 28, 2013, the NADAC for GABAPENTIN 300 MG CAPSULE has ranged from a low of $0.0396 (Apr 19, 2017) to a high of $0.0676 (Feb 12, 2014), with a median of $0.0470 per EA.
Are there cheaper alternatives to GABAPENTIN 300 MG CAPSULE?
Yes. 17 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, GABAPENTIN 300 MG CAPSULE, is $0.0301 per EA — about 42% below GABAPENTIN 300 MG CAPSULE.
Who manufactures GABAPENTIN 300 MG CAPSULE?
GABAPENTIN 300 MG CAPSULE (NDC 53746010210) is labeled by Amneal Pharmaceuticals of New York LLC, and CMS classifies it as a generic product.